TrackU: An Educational Self-tracking Tool for Identification of SARS-CoV-2 Risk Transmission

Sponsor
Hospital Clinic of Barcelona (Other)
Overall Status
Enrolling by invitation
CT.gov ID
NCT05171829
Collaborator
Escoles Universitaries Gimbernat (Other), University of Barcelona (Other), Barcelona Institute for Global Health (Other), Universitat Politècnica de Catalunya (Other), Universitat Oberta de Catalunya (Other)
180
1
2
4.6
39.4

Study Details

Study Description

Brief Summary

One way to empower a community, in epidemic control issues, is to know the first-hand screening tools. There are no evaluations of these home-use tools from the perspective of patient and citizen empowerment and participation. The main objective of this study is to analyze whether a self-tracking and self-tracing tool, developed in a participatory way, increases the risk identification of the disease and the empowerment in terms of risk management of transmission by the participants.

Condition or Disease Intervention/Treatment Phase
  • Other: Track U
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
180 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Masking Description:
Statistician masking
Primary Purpose:
Prevention
Official Title:
An Educational Self-tracking Tool for Identification of SARS-CoV-2 Risk Transmission: a Randomised Controlled Trial
Anticipated Study Start Date :
Dec 27, 2021
Anticipated Primary Completion Date :
May 15, 2022
Anticipated Study Completion Date :
May 15, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: Intervention : Educational tool

self-tracking educational tool (diary)

Other: Track U
Track U diary

No Intervention: Control

Outcome Measures

Primary Outcome Measures

  1. Risk identification of SARS-CoV 2 transmission [17 days]

    Risk identification of SARS-CoV 2 transmission

Secondary Outcome Measures

  1. Empowerment in SARS-CoV 2 transmission [17 days]

    Empowerment in SARS-CoV 2 transmission

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:

Fluent in Catalan or Spanish, Resident in Catalonia, Signs informed consent, Commitment to use the tool if he/she gets in intervention group.

Exclusion Criteria:

Language barrier and other conditions that do not allow self-completion of the survey Be a COVID case or contact at the time of recruitment.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Hospital Clinic de Barcelona Barcelona Spain 08036

Sponsors and Collaborators

  • Hospital Clinic of Barcelona
  • Escoles Universitaries Gimbernat
  • University of Barcelona
  • Barcelona Institute for Global Health
  • Universitat Politècnica de Catalunya
  • Universitat Oberta de Catalunya

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Anna Llupia, Public Health Specialist, Hospital Clinic of Barcelona
ClinicalTrials.gov Identifier:
NCT05171829
Other Study ID Numbers:
  • HCB/2021/1054
First Posted:
Dec 29, 2021
Last Update Posted:
Dec 29, 2021
Last Verified:
Dec 1, 2021
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Dec 29, 2021